Smith+Nephew Q3 Revenue Rises 3.4% YoY To $1.551B; $250M Of $500M Buyback Completed; Confirms Johnson & Johnson Talks Ended, Still Exploring Orthopaedics Strategic Options

Benzinga

2026.11.04 07:24 (GMT+0)

Öffnen unter Benzinga